US Bancorp
ANRO icon

US Bancorp’s Alto Neuroscience ANRO Stock Holding History

US Bancorp’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03K Sell
39
-71
-65% -$1.64K ﹤0.01% 3975
2026
Q1 		$2.47K Sell
110
-3
-3% -$56 ﹤0.01% 3756
2025
Q4 		$2.01K Buy
+113
New +$1.42K ﹤0.01% 3752
2024
Q4 		– Sell
-17
Closed -$194 – 4279
2024
Q3 		$194 Buy
+17
New +$208 ﹤0.01% 4015

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

US Bancorp's ANRO Position: Q2 2026 in Review

US Bancorp reduced its Alto Neuroscience (ANRO) stake by 65% in Q2 2026, selling an estimated $1.64K and leaving 39 shares worth $1.03K. The position accounts for ﹤0.01% of the portfolio, ranked #3975.

US Bancorp first reported a position in ANRO in Q3 2024 and has held it in 4 quarters since. The position peaked at $2.47K in Q1 2026. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • US Bancorp held 39 shares of Alto Neuroscience worth $1.03K as of Q2 2026.
  • US Bancorp sold 71 Alto Neuroscience shares in Q2 2026, an estimated $1.64K.
  • Alto Neuroscience made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3975 holding.
  • US Bancorp first reported a position in Alto Neuroscience in Q3 2024 and has held it in 4 quarters since.
  • US Bancorp's Alto Neuroscience position peaked at $2.47K in Q1 2026.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.